Cancer Research UK logo.
SearchDonate
  • Search

A trial of nab-paclitaxel with CC-486 and durvalumab for advanced non small cell lung cancer

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Phase 2

Details

This trial is for people who have already had treatment for their advanced non small cell lung cancer.

Advanced non small cell lung cancer (NSCLC) means that it has spread to another part of the body (metastatic) or into the surrounding tissue (locally advanced).

Recruitment start: 1 January 2016

Recruitment end: 19 December 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor D Talbot

Supported by

Experimental Cancer Medicine Centre (ECMC)

Celgene

Last reviewed: 6 January 2017

CRUK internal database number: 14119

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.